Furthermore, MKRN1 immunoreactivity was significantly correlated with advanced disease and poor outcome, including the FIGO stage (P=0.018, one-way ANOVA and independent t-test) and tumour grade (P<0.001, one-way ANOVA and independent t-test). The gene discussed is MKRN1; the disease is neoplasm.